ArticlePhysiological reports2025
Metabolic changes in dorsal root ganglia of newborn Wistar rats following LPS exposure to understand mechanisms of critical illness polyneuropathy.
Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a public health issue, associated with complications as critical illness polyneuropathy (CIP). This study investigates how mitochondrial dysfunction could contribute to CIP by examining metabolic changes in dorsal root ganglia (DRG) culture from newborn Wistar rats exposed to different concentrations of lipopolysaccharide (5, 10, 50, and 100 μg/mL for 24 or 48 h). Cell viability was assessed using the MTS assay, gene expression related to inflammation and mitochondrial function was analyzed by Real-Time PCR. IL-6 levels of supernatants were measured by ELISA and energetic metabolism was evaluated with the Seahorse MitoStress kit. Exposure to LPS at varying concentrations mainly did not affect cell viability, except at 10 μg/mL for 48 h, where a 7.5% increase was noted. Gene expression analysis showed trends in SOD2 and Fis1, with significant increases in IL-6 and LIF transcripts at 5 and 10 μg/mL. IL-6 release was significant at 50 and 100 μg/mL of LPS. Mitochondrial respiration and glycolytic metabolism exhibited significant changes in oxygen consumption rate and extracellular acidification, particularly at higher LPS concentrations. The findings suggest that LPS induces an inflammatory environment which led to metabolic disturbances in DRG cells, with adaptive responses at 10 and 50 μg/mL of LPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.